Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $117.5 million.

  • Harmony Biosciences Holdings' Income from Continuing Operations rose 10.35% to $50.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $157.7 million, marking a year-over-year increase of 44.38%. This contributed to the annual value of $117.5 million for FY2024, which is 1.78% up from last year.
  • As of FY2024, Harmony Biosciences Holdings' Income from Continuing Operations stood at $117.5 million, which was up 1.78% from $115.4 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Income from Continuing Operations ranged from a high of $181.5 million in FY2022 and a low of -$30.5 million during FY2020.
  • Its 3-year average for Income from Continuing Operations is $138.1 million, with a median of $117.5 million in 2024.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first skyrocketed by 486.50% in 2022, then plummeted by 36.39% in 2023.
  • Over the past 5 years, Harmony Biosciences Holdings' Income from Continuing Operations (Yearly) stood at -$30.5 million in 2020, then soared by 201.35% to $30.9 million in 2021, then surged by 486.50% to $181.5 million in 2022, then plummeted by 36.39% to $115.4 million in 2023, then climbed by 1.78% to $117.5 million in 2024.